Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastases
Titel:
Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastases
Auteur:
Zhang, Qing Lin, Jessica J. Pal, Navdeep Polito, Letizia Trinh, Huong Hilton, Magalie Smoljanović, Vlatka Kurtsikidze, Nino Archer, Venice Krebs, Matthew G.